Lttl Tirzepatide Review: Cost, a Full Public Price Matrix & Honest Verdict (2026)

Lttl: $199/month for semaglutide and $129/month figures both present on the site, consistent with roster data describing a full, publicly visible price matrix on a dedicated /plans page. Every fact here comes from the company's own published program.

What Lttl is

Lttl (pronounced "little") is a direct-to-consumer telehealth brand, offering compounded semaglutide and tirzepatide, a low-dose "microdose" line, and longevity peptides. It states plainly its compounded GLP-1s "are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality" — a genuinely clear disclosure.

A genuinely public price matrix

This is Lttl's standout transparency feature: it publishes the full price matrix — every medication, form, and commitment length — on a public /plans page before checkout. That's genuinely rarer than it should be in this category.

The "$129" headline requires a full year prepaid

$129/month appears on the site, but that's the 12-month prepay rate; true month-to-month is $199 for semaglutide and $279 for tirzepatide. The $199 figure is present. A microdose line prices low-dose semaglutide or tirzepatide at $149/month month-to-month.

The brand-vs-compounded question

Lttl dispenses compounded tirzepatide, with an unusually plain FDA disclaimer. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Lttl's real strengths: a genuinely public, full price matrix before checkout, flat dose pricing ("same price at every dose"), a plain, clear FDA disclaimer, and an oral ODT semaglutide option for members avoiding injections. The trade-offs: partner pharmacies are never named — only "a partner U.S. pharmacy" — the "$129" headline requires a 12-month prepay, with true month-to-month at $199/$279, no public state list exists, and the 48-hour shipping promise conflicts with a stated 2-5 day processing plus 3-7 day delivery policy, and medications can't be returned or refunded once shipped. As with any GLP-1 program, confirm which commitment length applies to your quote and don't expect a refund once medication ships; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Lttl's genuinely public price matrix and plain FDA disclaimer are real transparency positives this review confirmed directly, but the "$129" headline requires a full year prepaid — budget for $199-$279 month-to-month instead. For a provider with a named pharmacy at a similar structure, compare it against BiltRx or LevelUp Rx. For a provider whose tirzepatide price exists nowhere on its public site at all, only inside an in-app portal, see Pomegranate Health. See our best tirzepatide providers ranking for the full field.